Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancer
Brock J. Sishc,
No information about this author
Janapriya Saha,
No information about this author
E. Alves
No information about this author
et al.
npj Precision Oncology,
Journal Year:
2025,
Volume and Issue:
9(1)
Published: Jan. 17, 2025
Pancreatic
ductal
adenocarcinoma
(PDAC)
is
notably
resistant
to
conventional
chemotherapy
and
radiation
treatment.
However,
clinical
trials
indicate
that
carbon
ion
radiotherapy
(CIRT)
with
concurrent
gemcitabine
effective
for
unresectable
locally
advanced
PDAC.
This
study
aimed
identify
patient
characteristics
predictive
of
CIRT
response.
We
utilized
a
panel
human
PDAC
cell
lines
diverse
genetic
profiles
determine
their
sensitivity
compared
γ-rays,
assessing
relative
biological
effectiveness
(RBE)
at
10%
survival,
which
ranged
from
1.96
3.04.
Increased
radiosensitivity
was
linked
impaired
DNA
double-strand
break
(DSB)
repair,
particularly
in
deficiencies
the
homologous
recombination
(HR)
repair
pathway
and/or
elevated
genomic
instability
replication
stress.
Furthermore,
pretreatment
HR
inhibitor
B02
significantly
enhanced
radioresistant
line
when
irradiated
spread-out
Bragg
peak
but
not
entry
position
beam.
These
findings
suggest
tumors
mutations
or
high
stress
are
more
likely
benefit
while
minimizing
normal
tissue
toxicity.
Language: Английский
Effect of FLASH proton therapy on primary bronchial epithelial cell organoids
Clinical and Translational Radiation Oncology,
Journal Year:
2025,
Volume and Issue:
52, P. 100927 - 100927
Published: Jan. 29, 2025
The
effects
of
conventional
(CONV)
and
FLASH
proton
therapy
on
primary
bronchial
epithelial
cell
(PBEC)
organoids
from
individuals
with
chronic
obstructive
pulmonary
disease
(COPD)
were
investigated.
objective
was
to
compare
the
effect
CONV
COPD
PBEC
a
focus
DNA
damage,
organoid
formation,
gene
expression.
PBECs
obtained
six
donors,
cultured
as
three-dimensional
(3D)
exposed
2
8
Gy
radiation
at
Holland
Proton
Therapy
Center.
damage
assessed
by
γH2AX
staining.
Organoid
formation
capacity
counting
formed
after
reseeding
irradiated
cells
24
h
7
days.
Bulk
RNA
sequencing
(RNAseq)
qPCR
analyses
performed
identify
pathways
differences
in
response.
foci
analysis
showed
significant
dose-dependent
increase
1
for
both
treatments,
without
between
two
modalities.
assays
revealed
decrease
treatments.
At
days,
FLASH-treated
samples
significantly
reduced
compared
(p
=
0.008).
RNAseq
identified
FLASH-induced
changes
expression
DNA-damage
response
apoptosis
pathway
genes.
A
upregulation
MDM2,
GDF15,
DDB2,
BAX,
P21,
AEN
MKi67
confirmed
analysis.
No
found
or
profiles
FLASH.
assay
prolonged
detrimental
organoids,
suggesting
more
complex
interaction
lung
cells.
results
this
study
contribute
advancement
robust
vitro
human
models
investigating
mechanisms
action
FLASH,
potentially
facilitating
treatment
NSCLC
patients
therapy.
Language: Английский
Advancing Radiobiology: Investigating the Effects of Photon, Proton, and Carbon-Ion Irradiation on PANC-1 Cells in 2D and 3D Tumor Models
Current Oncology,
Journal Year:
2025,
Volume and Issue:
32(1), P. 49 - 49
Published: Jan. 18, 2025
Introduction:
Pancreatic
cancer
(PC)
is
one
of
the
most
aggressive
and
lethal
malignancies,
calling
for
enhanced
research.
ductal
adenocarcinoma
(PDAC)
represents
70–80%
all
cases
known
its
resistance
to
conventional
therapies.
Carbon-ion
radiotherapy
(CIRT)
has
emerged
as
a
promising
approach
due
ability
deliver
highly
localized
doses
unique
radiobiological
properties
compared
X-rays.
In
vitro
radiobiology
relied
on
two-dimensional
(2D)
cell
culture
models
so
far;
however,
these
are
not
sufficient
replicate
complexity
in
vivo
tumor
architecture.
Three-dimensional
(3D)
become
paradigm
shift,
surpassing
constraints
traditional
by
accurately
re-creating
morphological,
histological,
genetic
characteristics
well
interaction
tumour
cells
with
microenvironment.
Materials
Methods:
This
study
investigates
survival
pancreatic
both
2D
spheroids,
3D
model,
following
photon,
proton,
carbon-ion
irradiation
means
clonogenic,
MTT,
spheroid
growth,
vitality
assays.
Results:
Our
results
demonstrate
that
carbon
ions
more
efficient
reducing
photons
protons.
cultures,
reduced
approximately
15%,
45%
30%
growth
was
similarly
inhibited
irradiation;
overall
rates
were
higher
across
modalities
cultures.
Carbon
consistently
showed
highest
efficacy
viability
models.
Conclusions:
research
highlights
pivotal
role
unraveling
complexities
radiobiology,
offering
new
avenues
designing
effective
precise
treatment
protocols.
Language: Английский
AI in Radiopharmaceutical Development
P. Selvakumar,
No information about this author
M. Sivaraja,
No information about this author
P. Nehru
No information about this author
et al.
Advances in computational intelligence and robotics book series,
Journal Year:
2025,
Volume and Issue:
unknown, P. 93 - 116
Published: Feb. 28, 2025
Radiopharmaceuticals
are
a
specialized
class
of
compounds
used
in
These
compounds,
which
combine
radioactive
isotope
with
biologically
active
molecule,
hold
central
role
nuclear
medicine.
Their
ability
to
diagnose,
stage,
and
even
treat
diseases,
particularly
cancers,
makes
them
invaluable
tools
the
realm
modern
healthcare.
The
term
“radiopharmaceutical”
derives
from
two
words:
“radio”
“pharmaceutical”.
When
administered
patient,
radiopharmaceuticals
emit
radiation
that
can
be
detected
by
imaging
systems,
allowing
for
visualization
organ
tissue
function
morphology.
This
technique
is
widely
referred
as
or
molecular
imaging.
generally
categorized
into
primary
types:
diagnostic
therapeutic
radiopharmaceuticals.
former
designed
help
clinicians
visualize
evaluate
condition
organs
tissues,
aiding
diagnosis
disorders.
Language: Английский
Multi-Target Inhibitor CUDC-101 Impairs DNA Damage Repair and Enhances Radiation Response in Triple-Negative Breast Cell Line
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(11), P. 1467 - 1467
Published: Nov. 1, 2024
Since
the
discovery
that
Histone
deacetylase
inhibitors
(HDCAi)
could
enhance
radiation
response,
a
number
of
HDACi,
mainly
pan-HDAC
inhibitors,
have
been
studied
either
as
monotherapy
or
in
combination
with
X-ray
irradiation
chemotherapeutic
drugs
management
breast
cancer.
However,
studies
on
HDACi
and
proton
remain
limited.
CUDC-101
is
multitarget
inhibitor
deacetylases
(HDACs),
epidermal
growth
factor
receptor
(EGFR),
human
2
(HER-2).
In
this
paper,
effectiveness
enhancing
response
to
both
was
studied.
Language: Английский
In vitro FLASH irradiation of A549 lung cancer cells and IMR90 healthy human fibroblasts in the synchrocyclotron room of a clinical proton therapy system
Adrián Zazpe,
No information about this author
Inés del Monte-García,
No information about this author
Nerea Palao
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 15, 2024
Abstract
Purpose
This
study
aims
to
investigate
the
FLASH
irradiation
effect
on
lung
tumor
(A549)
and
healthy
fibroblast
(IMR90)
cell
lines
using
an
station
installed
at
synchrocyclotron
room
of
a
clinical
proton
facility
without
any
permanent
beamline
modifications.
Methods
Materials
An
system
composed
lead
scatterer
3D-printed
positioning
was
designed
fabricated
operate
within
gap
IBA
Proteus
One
therapy
after
extraction
beam
from
synchrocyclotron.
A
dosimetric
analysis
produced
field
carried
out
radiochromic
films.
conventional-rate
irradiations
were
conducted
relevant
for
cancer
isocenter
treatment
room.
Biological
assessments
post-irradiation
included
clonogenic
viability
assays
survival,
immunofluorescence
p21
protein
expression,
flow
cytometry
cycle
arrest
evaluation.
Results
The
successfully
delivered
homogeneous
repeatable
dose
rates
(>900
Gy/s)
with
accuracy
1
mm
uniformity
10%.
Clonogenic
revealed
no
statistically
significant
differences
in
survival
between
conventional
both
A549
IMR90
lines,
although
trend
towards
higher
observed
cells
under
conditions.
Flow
demonstrated
patterns
doses
above
7
Gy,
FLASH-irradiated
exhibiting
decrease
G2/M
phase
compared
rates.
Immunofluorescence
expression
showed
modalities.
Conclusions
developed
effectively
facilitates
radiotherapy
experiments
facility,
achieving
necessary
hardware
modification
or
extra
tuning
facility.
Our
reported
notable
alterations
dynamics
suggesting
distinct
biological
responses
cells.
These
findings
contribute
emerging
understanding
support
potential
its
differential
impact
cancerous
versus
tissues.
Language: Английский